Related Experiment Video
Updated: Jun 25, 2026

Generalized Psychophysiological Interaction (PPI) Analysis of Memory Related Connectivity in Individuals at Genetic Risk for Alzheimer's Disease
Published on: November 14, 2017
Accelerated hippocampal atrophy rates in stable and progressive amnestic mild cognitive impairment
Pei-Ning Wang1, Hsiu-Chih Liu, Jiing-Feng Lirng
1Department of Neurology, National Yang-Ming University School of Medicine, Taipei, Taiwan. pnwang@vghtpe.gov.tw
Abstract:
Studies suggest that smaller hippocampal volume predicts Alzheimer's disease (AD) in mild cognitive impairment (MCI). However, few studies have demonstrated decline rates in cognition and hippocampal volume in MCI subjects with stable clinical presentation. Furthermore, the effects of apolipoprotein E (ApoE) on the change rates of medial temporal structures and cognition in MCI are rarely investigated. Fifty-eight subjects with amnestic MCI and 20 normal aging elderly controls received annual neuropsychological and magnetic resonance imaging (MRI) assessments. Annual decline rates in neuropsychological test scores, hippocampal and amygdalar volumes were calculated. ApoE genotypes were examined. Nineteen (32.7%) MCI subjects converted to AD during an average 22.5-month follow-up period. The annual hippocampal atrophy rate was correlated with a decline in memory test scores. The presence of the ApoE varepsilon4 allele did not affect the change rates in neuropsychological test scores and medial temporal structures volume. Compared to subjects with stable MCI (MCI-S) and normal aging, progressive MCI (MCI-P) had the highest annual decline rates in cognition and hippocampal volume. Logistic regression analysis showed that higher annual decline rates in hippocampal volume and global cognitive test scores were associated with conversion to AD. Furthermore, although MCI-S subjects had little cognitive decline, their hippocampal atrophy rates were higher than those of normal aging controls. Therefore, accelerated hippocampal atrophy rates may be an early and important presentation in MCI subjects.
Insights
Accelerated hippocampal atrophy, a key indicator of brain shrinkage, may signal Alzheimer's disease progression in individuals with mild cognitive impairment (MCI). This finding is crucial for early diagnosis and intervention strategies.
Area of Science:
- Neuroscience
- Gerontology
- Radiology
Background:
- Smaller hippocampal volume is linked to Alzheimer's disease (AD) risk in mild cognitive impairment (MCI).
- Limited research exists on cognitive and hippocampal volume decline rates in stable MCI.
- The influence of apolipoprotein E (ApoE) on medial temporal structures and cognition changes in MCI is understudied.
Purpose of the Study:
- To investigate the rates of cognitive decline and hippocampal volume changes in amnestic MCI.
- To examine the impact of apolipoprotein E (ApoE) genotype on these decline rates.
- To identify predictors of conversion from MCI to AD.
Main Methods:
- Annual neuropsychological and MRI assessments were conducted on 58 amnestic MCI subjects and 20 controls.
- Annual decline rates in cognition, hippocampal, and amygdalar volumes were calculated.
- ApoE genotyping was performed, and logistic regression analyzed conversion predictors.
Main Results:
- Nineteen (32.7%) MCI subjects converted to AD within an average follow-up of 22.5 months.
- Annual hippocampal atrophy rate correlated with memory decline; ApoE varepsilon4 did not significantly affect change rates.
- Progressive MCI (MCI-P) showed higher cognitive and hippocampal volume decline rates than stable MCI (MCI-S) and controls.
- Higher rates of hippocampal atrophy and cognitive decline predicted conversion to AD.
- MCI-S subjects exhibited accelerated hippocampal atrophy compared to controls, despite minimal cognitive decline.
Conclusions:
- Accelerated hippocampal atrophy is a significant early indicator in MCI subjects, potentially predicting progression to Alzheimer's disease.
- Tracking hippocampal volume decline offers valuable insights into MCI progression and AD conversion risk.
- While ApoE varepsilon4 status did not influence rates in this cohort, hippocampal atrophy itself is a critical marker.
Related Concept Videos
Alzheimer Disease l: Introduction
Alzheimer Disease ll: Pathophysiology
Alzheimer's Disease: Overview
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
Dementia l: Introduction
Amnesia
The severity and duration of memory loss vary depending on the type and underlying cause. Amnesia is classified into two main types: retrograde and anterograde.
Retrograde amnesia is marked by the loss of memories formed before the onset of the condition. Patients may recall distant past events but often forget those occurring shortly before the incident.
Anterograde...
Role of Hippocampus in Memory
